Prim SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ES0170884417
  • MCE: PRM
EUR
12.60
0.1 (0.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Prim SA
Pangaea Oncology SA

Why is Prim SA ?

1
High Debt company with Weak Long Term Fundamental Strength
  • The company is Net-Debt Free
2
With ROE of 11.15%, it has a Very Expensive valuation with a 1.66 Price to Book Value
  • Over the past year, while the stock has generated a return of -6.67%, its profits have risen by 42% ; the PEG ratio of the company is 0.4
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -6.67% returns in the last 1 year, the stock has also underperformed Spain IBEX 35 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Prim SA for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Prim SA
-6.67%
-0.10
22.83%
Spain IBEX 35
23.16%
1.40
16.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.99%
EBIT Growth (5y)
14.03%
EBIT to Interest (avg)
15.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
1.36
Tax Ratio
24.30%
Dividend Payout Ratio
43.67%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
256.99%
ROE (avg)
232.45%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.66
EV to EBIT
11.93
EV to EBITDA
8.18
EV to Capital Employed
1.72
EV to Sales
1.09
PEG Ratio
0.35
Dividend Yield
3.65%
ROCE (Latest)
14.45%
ROE (Latest)
11.15%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Footer loading